➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
Boehringer Ingelheim
Medtronic
Merck
Johnson and Johnson

Last Updated: July 5, 2020

DrugPatentWatch Database Preview

Glenmark Pharms Inc Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for GLENMARK PHARMS INC, and what generic and branded alternatives to GLENMARK PHARMS INC drugs are available?

GLENMARK PHARMS INC has six approved drugs.



Summary for Glenmark Pharms Inc
US Patents:0
Tradenames:6
Ingredients:6
NDAs:6

Drugs and US Patents for Glenmark Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark Pharms Inc CALCIPOTRIENE calcipotriene OINTMENT;TOPICAL 090633-001 Mar 24, 2010 RX No Yes   Start Trial   Start Trial
Glenmark Pharms Inc FULVESTRANT fulvestrant INJECTABLE;INTRAMUSCULAR 207754-001 Aug 22, 2019 AO RX No No   Start Trial   Start Trial
Glenmark Pharms Inc LITHIUM CARBONATE lithium carbonate TABLET, EXTENDED RELEASE;ORAL 091544-001 Dec 27, 2010 AB RX No No   Start Trial   Start Trial
Glenmark Pharms Inc MUPIROCIN mupirocin calcium CREAM;TOPICAL 201587-001 Jan 24, 2013 AB RX No Yes   Start Trial   Start Trial
Glenmark Pharms Inc RANITIDINE HYDROCHLORIDE ranitidine hydrochloride TABLET;ORAL 078542-002 Nov 19, 2008 AB RX No No   Start Trial   Start Trial
Glenmark Pharms Inc SOLIFENACIN SUCCINATE solifenacin succinate TABLET;ORAL 209239-002 May 20, 2019 AB RX No No   Start Trial   Start Trial
Glenmark Pharms Inc SOLIFENACIN SUCCINATE solifenacin succinate TABLET;ORAL 209239-001 May 20, 2019 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Johnson and Johnson
McKesson
Harvard Business School
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.